You have no items in your shopping cart.
TAZ Antibody Blocking peptide
SKU: orb1444835
Description
Research Area
Cardiovascular Disease
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Protein Sequence | The synthetic peptide sequence used to generate the antibody orb1928273 was selected from the N-term region of human TAZ. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
|---|
Storage & Handling
−| Form/Appearance | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Tafazzin, Protein G45, TAZ, EFE2, G45
Similar Products
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt
UniProt Details
− No UniProt data available
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
TAZ Antibody Blocking peptide (orb1444835)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review